By Rich Haridy June 19, 2022 The new data reports nearly 100 percent success in 75 patients treated with efficacy persisting up to three years beyond the initial treatment Depositphotos Incredible new data presented recently at the European Hematology Association Congress has revealed an experimental CRISPR gene editing therapy is both safe and effective up...
